PlainRecalls
FDA Drug Low Class III Terminated

Pramipexole Dihydrochloride Tablets 0.125 mg,90-count bottle, Rx Only, Manufactured for: Macleods Pharma USA, Inc. Plainsboro, NJ 08536, Manufactured by: Macleods Phamaceuticals Ltd. Baddi Himachal Pradesh, India. NDC 33342-031-10

Reported: September 18, 2019 Initiated: August 21, 2019 #D-1851-2019

Product Description

Pramipexole Dihydrochloride Tablets 0.125 mg,90-count bottle, Rx Only, Manufactured for: Macleods Pharma USA, Inc. Plainsboro, NJ 08536, Manufactured by: Macleods Phamaceuticals Ltd. Baddi Himachal Pradesh, India. NDC 33342-031-10

Reason for Recall

Subpotent Drug: Out of specification result during stability study in Pramipexole Dihydrochloride Tablets 0.125 mg

Details

Recalling Firm
Macleods Pharma Usa Inc
Units Affected
1837 90-count bottles
Distribution
Distributed Nationwide in the USA
Location
Plainsboro, NJ

Frequently Asked Questions

What product was recalled?
Pramipexole Dihydrochloride Tablets 0.125 mg,90-count bottle, Rx Only, Manufactured for: Macleods Pharma USA, Inc. Plainsboro, NJ 08536, Manufactured by: Macleods Phamaceuticals Ltd. Baddi Himachal Pradesh, India. NDC 33342-031-10. Recalled by Macleods Pharma Usa Inc. Units affected: 1837 90-count bottles.
Why was this product recalled?
Subpotent Drug: Out of specification result during stability study in Pramipexole Dihydrochloride Tablets 0.125 mg
Which agency issued this recall?
This recall was issued by the FDA Drug on September 18, 2019. Severity: Low. Recall number: D-1851-2019.